The task of building drug access for one billion new customers in China is probably this decade’s grandest public policy experiment. It is taking place largely behind the scene in a series of often tense exchanges between Beijing and local governments – the dialogue is worth watching for the long-term commercial implications in what all [...]
Drug Payment Reform in China: Now That's a Mass Market